nodes	percent_of_prediction	percent_of_DWPC	metapath
Pramipexole—Parkinson's disease—Memantine—Alzheimer's disease	0.223	0.5	CpDpCtD
Pramipexole—Parkinson's disease—Rivastigmine—Alzheimer's disease	0.223	0.5	CpDpCtD
Pramipexole—HTR2A—Alzheimer's disease	0.108	1	CbGaD
Pramipexole—SLC22A2—Memantine—Alzheimer's disease	0.0787	0.39	CbGbCtD
Pramipexole—HTR2A—Donepezil—Alzheimer's disease	0.0684	0.339	CbGbCtD
Pramipexole—DRD2—Memantine—Alzheimer's disease	0.0547	0.271	CbGbCtD
Pramipexole—HTR2C—choroid plexus—Alzheimer's disease	0.0055	0.122	CbGeAlD
Pramipexole—DRD3—telencephalic ventricle—Alzheimer's disease	0.0029	0.064	CbGeAlD
Pramipexole—HTR2A—choroid plexus—Alzheimer's disease	0.00276	0.061	CbGeAlD
Pramipexole—DRD1—telencephalic ventricle—Alzheimer's disease	0.00207	0.0459	CbGeAlD
Pramipexole—HTR2A—locus ceruleus—Alzheimer's disease	0.0017	0.0377	CbGeAlD
Pramipexole—HTR1B—telencephalic ventricle—Alzheimer's disease	0.00168	0.0372	CbGeAlD
Pramipexole—HTR1D—telencephalic ventricle—Alzheimer's disease	0.00163	0.036	CbGeAlD
Pramipexole—HTR2C—telencephalic ventricle—Alzheimer's disease	0.00161	0.0356	CbGeAlD
Pramipexole—HTR2A—cerebellar cortex—Alzheimer's disease	0.00139	0.0307	CbGeAlD
Pramipexole—HTR1A—telencephalic ventricle—Alzheimer's disease	0.00136	0.03	CbGeAlD
Pramipexole—DRD2—telencephalic ventricle—Alzheimer's disease	0.00123	0.0271	CbGeAlD
Pramipexole—HTR1B—blood vessel—Alzheimer's disease	0.000832	0.0184	CbGeAlD
Pramipexole—HTR2A—telencephalic ventricle—Alzheimer's disease	0.000808	0.0179	CbGeAlD
Pramipexole—HTR1D—blood vessel—Alzheimer's disease	0.000805	0.0178	CbGeAlD
Pramipexole—DRD5—forebrain—Alzheimer's disease	0.000709	0.0157	CbGeAlD
Pramipexole—DRD5—telencephalon—Alzheimer's disease	0.000652	0.0144	CbGeAlD
Pramipexole—DRD1—forebrain—Alzheimer's disease	0.000542	0.012	CbGeAlD
Pramipexole—DRD1—telencephalon—Alzheimer's disease	0.000498	0.011	CbGeAlD
Pramipexole—DRD4—brain—Alzheimer's disease	0.000447	0.00987	CbGeAlD
Pramipexole—HTR1B—forebrain—Alzheimer's disease	0.000439	0.0097	CbGeAlD
Pramipexole—SLC22A1—forebrain—Alzheimer's disease	0.000429	0.00948	CbGeAlD
Pramipexole—HTR1D—forebrain—Alzheimer's disease	0.000425	0.00939	CbGeAlD
Pramipexole—HTR2C—forebrain—Alzheimer's disease	0.000421	0.0093	CbGeAlD
Pramipexole—DRD3—nervous system—Alzheimer's disease	0.000411	0.00908	CbGeAlD
Pramipexole—HTR1B—telencephalon—Alzheimer's disease	0.000404	0.00892	CbGeAlD
Pramipexole—HTR2A—blood vessel—Alzheimer's disease	0.0004	0.00884	CbGeAlD
Pramipexole—DRD3—central nervous system—Alzheimer's disease	0.000395	0.00874	CbGeAlD
Pramipexole—HTR2B—forebrain—Alzheimer's disease	0.000395	0.00874	CbGeAlD
Pramipexole—SLC22A1—telencephalon—Alzheimer's disease	0.000394	0.00872	CbGeAlD
Pramipexole—HTR1D—telencephalon—Alzheimer's disease	0.000391	0.00864	CbGeAlD
Pramipexole—HTR2C—telencephalon—Alzheimer's disease	0.000387	0.00855	CbGeAlD
Pramipexole—DRD5—nervous system—Alzheimer's disease	0.000385	0.00851	CbGeAlD
Pramipexole—DRD5—central nervous system—Alzheimer's disease	0.000371	0.00819	CbGeAlD
Pramipexole—HTR2B—telencephalon—Alzheimer's disease	0.000363	0.00803	CbGeAlD
Pramipexole—HTR1A—forebrain—Alzheimer's disease	0.000354	0.00783	CbGeAlD
Pramipexole—HTR1A—telencephalon—Alzheimer's disease	0.000326	0.0072	CbGeAlD
Pramipexole—DRD2—forebrain—Alzheimer's disease	0.00032	0.00707	CbGeAlD
Pramipexole—DRD3—brain—Alzheimer's disease	0.000314	0.00694	CbGeAlD
Pramipexole—DRD2—telencephalon—Alzheimer's disease	0.000294	0.00651	CbGeAlD
Pramipexole—DRD5—brain—Alzheimer's disease	0.000294	0.0065	CbGeAlD
Pramipexole—DRD1—nervous system—Alzheimer's disease	0.000294	0.0065	CbGeAlD
Pramipexole—ADRA2C—telencephalon—Alzheimer's disease	0.000286	0.00632	CbGeAlD
Pramipexole—DRD1—central nervous system—Alzheimer's disease	0.000283	0.00626	CbGeAlD
Pramipexole—ADRA2A—forebrain—Alzheimer's disease	0.000248	0.00549	CbGeAlD
Pramipexole—HTR2A—embryo—Alzheimer's disease	0.000239	0.00528	CbGeAlD
Pramipexole—HTR1B—nervous system—Alzheimer's disease	0.000238	0.00527	CbGeAlD
Pramipexole—SLC22A1—nervous system—Alzheimer's disease	0.000233	0.00515	CbGeAlD
Pramipexole—HTR1D—nervous system—Alzheimer's disease	0.000231	0.0051	CbGeAlD
Pramipexole—HTR1B—central nervous system—Alzheimer's disease	0.000229	0.00507	CbGeAlD
Pramipexole—HTR2C—nervous system—Alzheimer's disease	0.000228	0.00505	CbGeAlD
Pramipexole—ADRA2A—telencephalon—Alzheimer's disease	0.000228	0.00505	CbGeAlD
Pramipexole—DRD1—brain—Alzheimer's disease	0.000225	0.00497	CbGeAlD
Pramipexole—SLC22A1—central nervous system—Alzheimer's disease	0.000224	0.00495	CbGeAlD
Pramipexole—HTR1D—central nervous system—Alzheimer's disease	0.000222	0.00491	CbGeAlD
Pramipexole—HTR2C—central nervous system—Alzheimer's disease	0.00022	0.00486	CbGeAlD
Pramipexole—HTR2B—nervous system—Alzheimer's disease	0.000215	0.00474	CbGeAlD
Pramipexole—HTR2A—forebrain—Alzheimer's disease	0.000211	0.00467	CbGeAlD
Pramipexole—HTR2B—central nervous system—Alzheimer's disease	0.000207	0.00457	CbGeAlD
Pramipexole—HTR2A—telencephalon—Alzheimer's disease	0.000194	0.00429	CbGeAlD
Pramipexole—HTR1A—nervous system—Alzheimer's disease	0.000192	0.00425	CbGeAlD
Pramipexole—HTR1A—central nervous system—Alzheimer's disease	0.000185	0.00409	CbGeAlD
Pramipexole—HTR1B—brain—Alzheimer's disease	0.000182	0.00403	CbGeAlD
Pramipexole—HTR1A—cerebellum—Alzheimer's disease	0.000181	0.004	CbGeAlD
Pramipexole—SLC22A1—brain—Alzheimer's disease	0.000178	0.00393	CbGeAlD
Pramipexole—HTR1D—brain—Alzheimer's disease	0.000176	0.0039	CbGeAlD
Pramipexole—HTR2C—brain—Alzheimer's disease	0.000175	0.00386	CbGeAlD
Pramipexole—DRD2—nervous system—Alzheimer's disease	0.000174	0.00384	CbGeAlD
Pramipexole—ADRA2C—nervous system—Alzheimer's disease	0.000169	0.00373	CbGeAlD
Pramipexole—DRD2—central nervous system—Alzheimer's disease	0.000167	0.0037	CbGeAlD
Pramipexole—HTR2B—brain—Alzheimer's disease	0.000164	0.00363	CbGeAlD
Pramipexole—DRD2—cerebellum—Alzheimer's disease	0.000163	0.00361	CbGeAlD
Pramipexole—ADRA2C—central nervous system—Alzheimer's disease	0.000163	0.00359	CbGeAlD
Pramipexole—ADRA2C—cerebellum—Alzheimer's disease	0.000159	0.00351	CbGeAlD
Pramipexole—HTR1A—brain—Alzheimer's disease	0.000147	0.00325	CbGeAlD
Pramipexole—ADRA2A—nervous system—Alzheimer's disease	0.000135	0.00298	CbGeAlD
Pramipexole—DRD2—brain—Alzheimer's disease	0.000133	0.00294	CbGeAlD
Pramipexole—ADRA2A—central nervous system—Alzheimer's disease	0.00013	0.00287	CbGeAlD
Pramipexole—ADRA2C—brain—Alzheimer's disease	0.000129	0.00285	CbGeAlD
Pramipexole—ADRA2A—cerebellum—Alzheimer's disease	0.000127	0.0028	CbGeAlD
Pramipexole—HTR2A—nervous system—Alzheimer's disease	0.000115	0.00253	CbGeAlD
Pramipexole—HTR2A—central nervous system—Alzheimer's disease	0.00011	0.00244	CbGeAlD
Pramipexole—HTR2A—cerebellum—Alzheimer's disease	0.000108	0.00238	CbGeAlD
Pramipexole—ADRA2A—brain—Alzheimer's disease	0.000103	0.00228	CbGeAlD
Pramipexole—HTR2A—brain—Alzheimer's disease	8.76e-05	0.00194	CbGeAlD
Pramipexole—Tachycardia—Galantamine—Alzheimer's disease	5.87e-05	0.000393	CcSEcCtD
Pramipexole—Oedema peripheral—Memantine—Alzheimer's disease	5.86e-05	0.000393	CcSEcCtD
Pramipexole—Connective tissue disorder—Memantine—Alzheimer's disease	5.85e-05	0.000392	CcSEcCtD
Pramipexole—Rhinitis—Rivastigmine—Alzheimer's disease	5.84e-05	0.000391	CcSEcCtD
Pramipexole—Skin disorder—Galantamine—Alzheimer's disease	5.84e-05	0.000391	CcSEcCtD
Pramipexole—Urethral disorder—Memantine—Alzheimer's disease	5.83e-05	0.000391	CcSEcCtD
Pramipexole—Hyperhidrosis—Galantamine—Alzheimer's disease	5.81e-05	0.00039	CcSEcCtD
Pramipexole—Hallucination—Rivastigmine—Alzheimer's disease	5.79e-05	0.000388	CcSEcCtD
Pramipexole—Hypoaesthesia—Rivastigmine—Alzheimer's disease	5.79e-05	0.000388	CcSEcCtD
Pramipexole—Alopecia—Donepezil—Alzheimer's disease	5.79e-05	0.000388	CcSEcCtD
Pramipexole—Pharyngitis—Rivastigmine—Alzheimer's disease	5.78e-05	0.000388	CcSEcCtD
Pramipexole—Urinary tract disorder—Rivastigmine—Alzheimer's disease	5.75e-05	0.000386	CcSEcCtD
Pramipexole—Mental disorder—Donepezil—Alzheimer's disease	5.74e-05	0.000385	CcSEcCtD
Pramipexole—Oedema peripheral—Rivastigmine—Alzheimer's disease	5.74e-05	0.000385	CcSEcCtD
Pramipexole—Visual impairment—Memantine—Alzheimer's disease	5.74e-05	0.000385	CcSEcCtD
Pramipexole—Anorexia—Galantamine—Alzheimer's disease	5.73e-05	0.000384	CcSEcCtD
Pramipexole—Connective tissue disorder—Rivastigmine—Alzheimer's disease	5.72e-05	0.000384	CcSEcCtD
Pramipexole—Urethral disorder—Rivastigmine—Alzheimer's disease	5.71e-05	0.000383	CcSEcCtD
Pramipexole—Malnutrition—Donepezil—Alzheimer's disease	5.71e-05	0.000383	CcSEcCtD
Pramipexole—Erythema—Donepezil—Alzheimer's disease	5.71e-05	0.000383	CcSEcCtD
Pramipexole—Flatulence—Donepezil—Alzheimer's disease	5.62e-05	0.000377	CcSEcCtD
Pramipexole—Hypotension—Galantamine—Alzheimer's disease	5.62e-05	0.000377	CcSEcCtD
Pramipexole—Visual impairment—Rivastigmine—Alzheimer's disease	5.61e-05	0.000376	CcSEcCtD
Pramipexole—Tension—Donepezil—Alzheimer's disease	5.6e-05	0.000375	CcSEcCtD
Pramipexole—Dysgeusia—Donepezil—Alzheimer's disease	5.59e-05	0.000375	CcSEcCtD
Pramipexole—Eye disorder—Memantine—Alzheimer's disease	5.56e-05	0.000373	CcSEcCtD
Pramipexole—Tinnitus—Memantine—Alzheimer's disease	5.55e-05	0.000372	CcSEcCtD
Pramipexole—Nervousness—Donepezil—Alzheimer's disease	5.54e-05	0.000372	CcSEcCtD
Pramipexole—Cardiac disorder—Memantine—Alzheimer's disease	5.52e-05	0.00037	CcSEcCtD
Pramipexole—Flushing—Memantine—Alzheimer's disease	5.52e-05	0.00037	CcSEcCtD
Pramipexole—Back pain—Donepezil—Alzheimer's disease	5.52e-05	0.00037	CcSEcCtD
Pramipexole—Muscle spasms—Donepezil—Alzheimer's disease	5.49e-05	0.000368	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	5.48e-05	0.000367	CcSEcCtD
Pramipexole—Eye disorder—Rivastigmine—Alzheimer's disease	5.44e-05	0.000365	CcSEcCtD
Pramipexole—Insomnia—Galantamine—Alzheimer's disease	5.44e-05	0.000364	CcSEcCtD
Pramipexole—Tinnitus—Rivastigmine—Alzheimer's disease	5.43e-05	0.000364	CcSEcCtD
Pramipexole—Flushing—Rivastigmine—Alzheimer's disease	5.4e-05	0.000362	CcSEcCtD
Pramipexole—Cardiac disorder—Rivastigmine—Alzheimer's disease	5.4e-05	0.000362	CcSEcCtD
Pramipexole—Angiopathy—Memantine—Alzheimer's disease	5.4e-05	0.000362	CcSEcCtD
Pramipexole—Paraesthesia—Galantamine—Alzheimer's disease	5.4e-05	0.000362	CcSEcCtD
Pramipexole—Vision blurred—Donepezil—Alzheimer's disease	5.38e-05	0.000361	CcSEcCtD
Pramipexole—Immune system disorder—Memantine—Alzheimer's disease	5.38e-05	0.00036	CcSEcCtD
Pramipexole—Mediastinal disorder—Memantine—Alzheimer's disease	5.36e-05	0.00036	CcSEcCtD
Pramipexole—Tremor—Donepezil—Alzheimer's disease	5.35e-05	0.000358	CcSEcCtD
Pramipexole—Somnolence—Galantamine—Alzheimer's disease	5.34e-05	0.000358	CcSEcCtD
Pramipexole—Chills—Memantine—Alzheimer's disease	5.34e-05	0.000358	CcSEcCtD
Pramipexole—Ill-defined disorder—Donepezil—Alzheimer's disease	5.29e-05	0.000355	CcSEcCtD
Pramipexole—Dyspepsia—Galantamine—Alzheimer's disease	5.29e-05	0.000355	CcSEcCtD
Pramipexole—Angiopathy—Rivastigmine—Alzheimer's disease	5.28e-05	0.000354	CcSEcCtD
Pramipexole—Anaemia—Donepezil—Alzheimer's disease	5.27e-05	0.000354	CcSEcCtD
Pramipexole—Alopecia—Memantine—Alzheimer's disease	5.26e-05	0.000353	CcSEcCtD
Pramipexole—Mediastinal disorder—Rivastigmine—Alzheimer's disease	5.25e-05	0.000352	CcSEcCtD
Pramipexole—Agitation—Donepezil—Alzheimer's disease	5.24e-05	0.000352	CcSEcCtD
Pramipexole—Chills—Rivastigmine—Alzheimer's disease	5.22e-05	0.00035	CcSEcCtD
Pramipexole—Decreased appetite—Galantamine—Alzheimer's disease	5.22e-05	0.00035	CcSEcCtD
Pramipexole—Mental disorder—Memantine—Alzheimer's disease	5.21e-05	0.00035	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Galantamine—Alzheimer's disease	5.19e-05	0.000348	CcSEcCtD
Pramipexole—Malnutrition—Memantine—Alzheimer's disease	5.18e-05	0.000347	CcSEcCtD
Pramipexole—Fatigue—Galantamine—Alzheimer's disease	5.18e-05	0.000347	CcSEcCtD
Pramipexole—Malaise—Donepezil—Alzheimer's disease	5.15e-05	0.000345	CcSEcCtD
Pramipexole—Alopecia—Rivastigmine—Alzheimer's disease	5.15e-05	0.000345	CcSEcCtD
Pramipexole—Constipation—Galantamine—Alzheimer's disease	5.14e-05	0.000345	CcSEcCtD
Pramipexole—Vertigo—Donepezil—Alzheimer's disease	5.13e-05	0.000344	CcSEcCtD
Pramipexole—Syncope—Donepezil—Alzheimer's disease	5.12e-05	0.000343	CcSEcCtD
Pramipexole—Flatulence—Memantine—Alzheimer's disease	5.11e-05	0.000342	CcSEcCtD
Pramipexole—Mental disorder—Rivastigmine—Alzheimer's disease	5.1e-05	0.000342	CcSEcCtD
Pramipexole—Tension—Memantine—Alzheimer's disease	5.08e-05	0.000341	CcSEcCtD
Pramipexole—Dysgeusia—Memantine—Alzheimer's disease	5.07e-05	0.00034	CcSEcCtD
Pramipexole—Malnutrition—Rivastigmine—Alzheimer's disease	5.07e-05	0.00034	CcSEcCtD
Pramipexole—Erythema—Rivastigmine—Alzheimer's disease	5.07e-05	0.00034	CcSEcCtD
Pramipexole—Nervousness—Memantine—Alzheimer's disease	5.03e-05	0.000337	CcSEcCtD
Pramipexole—Loss of consciousness—Donepezil—Alzheimer's disease	5.02e-05	0.000336	CcSEcCtD
Pramipexole—Back pain—Memantine—Alzheimer's disease	5.01e-05	0.000336	CcSEcCtD
Pramipexole—Flatulence—Rivastigmine—Alzheimer's disease	4.99e-05	0.000335	CcSEcCtD
Pramipexole—Cough—Donepezil—Alzheimer's disease	4.98e-05	0.000334	CcSEcCtD
Pramipexole—Tension—Rivastigmine—Alzheimer's disease	4.97e-05	0.000334	CcSEcCtD
Pramipexole—Dysgeusia—Rivastigmine—Alzheimer's disease	4.96e-05	0.000333	CcSEcCtD
Pramipexole—Feeling abnormal—Galantamine—Alzheimer's disease	4.95e-05	0.000332	CcSEcCtD
Pramipexole—Convulsion—Donepezil—Alzheimer's disease	4.94e-05	0.000332	CcSEcCtD
Pramipexole—Hypertension—Donepezil—Alzheimer's disease	4.93e-05	0.00033	CcSEcCtD
Pramipexole—Nervousness—Rivastigmine—Alzheimer's disease	4.92e-05	0.00033	CcSEcCtD
Pramipexole—Gastrointestinal pain—Galantamine—Alzheimer's disease	4.91e-05	0.00033	CcSEcCtD
Pramipexole—Back pain—Rivastigmine—Alzheimer's disease	4.9e-05	0.000329	CcSEcCtD
Pramipexole—Vision blurred—Memantine—Alzheimer's disease	4.88e-05	0.000327	CcSEcCtD
Pramipexole—Muscle spasms—Rivastigmine—Alzheimer's disease	4.87e-05	0.000327	CcSEcCtD
Pramipexole—Arthralgia—Donepezil—Alzheimer's disease	4.86e-05	0.000326	CcSEcCtD
Pramipexole—Chest pain—Donepezil—Alzheimer's disease	4.86e-05	0.000326	CcSEcCtD
Pramipexole—Myalgia—Donepezil—Alzheimer's disease	4.86e-05	0.000326	CcSEcCtD
Pramipexole—Tremor—Memantine—Alzheimer's disease	4.85e-05	0.000326	CcSEcCtD
Pramipexole—Anxiety—Donepezil—Alzheimer's disease	4.84e-05	0.000325	CcSEcCtD
Pramipexole—Ill-defined disorder—Memantine—Alzheimer's disease	4.81e-05	0.000322	CcSEcCtD
Pramipexole—Discomfort—Donepezil—Alzheimer's disease	4.8e-05	0.000322	CcSEcCtD
Pramipexole—Anaemia—Memantine—Alzheimer's disease	4.79e-05	0.000321	CcSEcCtD
Pramipexole—Vision blurred—Rivastigmine—Alzheimer's disease	4.78e-05	0.00032	CcSEcCtD
Pramipexole—Agitation—Memantine—Alzheimer's disease	4.76e-05	0.000319	CcSEcCtD
Pramipexole—Dry mouth—Donepezil—Alzheimer's disease	4.75e-05	0.000319	CcSEcCtD
Pramipexole—Body temperature increased—Galantamine—Alzheimer's disease	4.75e-05	0.000319	CcSEcCtD
Pramipexole—Abdominal pain—Galantamine—Alzheimer's disease	4.75e-05	0.000319	CcSEcCtD
Pramipexole—Tremor—Rivastigmine—Alzheimer's disease	4.75e-05	0.000318	CcSEcCtD
Pramipexole—Ill-defined disorder—Rivastigmine—Alzheimer's disease	4.7e-05	0.000315	CcSEcCtD
Pramipexole—Confusional state—Donepezil—Alzheimer's disease	4.7e-05	0.000315	CcSEcCtD
Pramipexole—Anaemia—Rivastigmine—Alzheimer's disease	4.68e-05	0.000314	CcSEcCtD
Pramipexole—Malaise—Memantine—Alzheimer's disease	4.67e-05	0.000313	CcSEcCtD
Pramipexole—Agitation—Rivastigmine—Alzheimer's disease	4.66e-05	0.000312	CcSEcCtD
Pramipexole—Oedema—Donepezil—Alzheimer's disease	4.66e-05	0.000312	CcSEcCtD
Pramipexole—Vertigo—Memantine—Alzheimer's disease	4.66e-05	0.000312	CcSEcCtD
Pramipexole—Syncope—Memantine—Alzheimer's disease	4.65e-05	0.000312	CcSEcCtD
Pramipexole—Leukopenia—Memantine—Alzheimer's disease	4.64e-05	0.000311	CcSEcCtD
Pramipexole—Infection—Donepezil—Alzheimer's disease	4.63e-05	0.00031	CcSEcCtD
Pramipexole—Shock—Donepezil—Alzheimer's disease	4.58e-05	0.000307	CcSEcCtD
Pramipexole—Palpitations—Memantine—Alzheimer's disease	4.58e-05	0.000307	CcSEcCtD
Pramipexole—Malaise—Rivastigmine—Alzheimer's disease	4.57e-05	0.000307	CcSEcCtD
Pramipexole—Nervous system disorder—Donepezil—Alzheimer's disease	4.57e-05	0.000306	CcSEcCtD
Pramipexole—Thrombocytopenia—Donepezil—Alzheimer's disease	4.56e-05	0.000306	CcSEcCtD
Pramipexole—Vertigo—Rivastigmine—Alzheimer's disease	4.55e-05	0.000305	CcSEcCtD
Pramipexole—Loss of consciousness—Memantine—Alzheimer's disease	4.55e-05	0.000305	CcSEcCtD
Pramipexole—Syncope—Rivastigmine—Alzheimer's disease	4.55e-05	0.000305	CcSEcCtD
Pramipexole—Cough—Memantine—Alzheimer's disease	4.52e-05	0.000303	CcSEcCtD
Pramipexole—Hyperhidrosis—Donepezil—Alzheimer's disease	4.5e-05	0.000302	CcSEcCtD
Pramipexole—Convulsion—Memantine—Alzheimer's disease	4.49e-05	0.000301	CcSEcCtD
Pramipexole—Palpitations—Rivastigmine—Alzheimer's disease	4.48e-05	0.0003	CcSEcCtD
Pramipexole—Hypertension—Memantine—Alzheimer's disease	4.47e-05	0.0003	CcSEcCtD
Pramipexole—Loss of consciousness—Rivastigmine—Alzheimer's disease	4.45e-05	0.000299	CcSEcCtD
Pramipexole—Anorexia—Donepezil—Alzheimer's disease	4.44e-05	0.000298	CcSEcCtD
Pramipexole—Hypersensitivity—Galantamine—Alzheimer's disease	4.43e-05	0.000297	CcSEcCtD
Pramipexole—Cough—Rivastigmine—Alzheimer's disease	4.42e-05	0.000297	CcSEcCtD
Pramipexole—Chest pain—Memantine—Alzheimer's disease	4.41e-05	0.000296	CcSEcCtD
Pramipexole—Myalgia—Memantine—Alzheimer's disease	4.41e-05	0.000296	CcSEcCtD
Pramipexole—Arthralgia—Memantine—Alzheimer's disease	4.41e-05	0.000296	CcSEcCtD
Pramipexole—Anxiety—Memantine—Alzheimer's disease	4.4e-05	0.000295	CcSEcCtD
Pramipexole—Convulsion—Rivastigmine—Alzheimer's disease	4.39e-05	0.000294	CcSEcCtD
Pramipexole—Hypertension—Rivastigmine—Alzheimer's disease	4.38e-05	0.000293	CcSEcCtD
Pramipexole—Discomfort—Memantine—Alzheimer's disease	4.36e-05	0.000292	CcSEcCtD
Pramipexole—Hypotension—Donepezil—Alzheimer's disease	4.35e-05	0.000292	CcSEcCtD
Pramipexole—Arthralgia—Rivastigmine—Alzheimer's disease	4.32e-05	0.000289	CcSEcCtD
Pramipexole—Chest pain—Rivastigmine—Alzheimer's disease	4.32e-05	0.000289	CcSEcCtD
Pramipexole—Myalgia—Rivastigmine—Alzheimer's disease	4.32e-05	0.000289	CcSEcCtD
Pramipexole—Dry mouth—Memantine—Alzheimer's disease	4.31e-05	0.000289	CcSEcCtD
Pramipexole—Asthenia—Galantamine—Alzheimer's disease	4.31e-05	0.000289	CcSEcCtD
Pramipexole—Anxiety—Rivastigmine—Alzheimer's disease	4.3e-05	0.000288	CcSEcCtD
Pramipexole—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	4.29e-05	0.000287	CcSEcCtD
Pramipexole—Confusional state—Memantine—Alzheimer's disease	4.26e-05	0.000286	CcSEcCtD
Pramipexole—Discomfort—Rivastigmine—Alzheimer's disease	4.26e-05	0.000286	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	4.24e-05	0.000285	CcSEcCtD
Pramipexole—Oedema—Memantine—Alzheimer's disease	4.23e-05	0.000284	CcSEcCtD
Pramipexole—Dry mouth—Rivastigmine—Alzheimer's disease	4.22e-05	0.000283	CcSEcCtD
Pramipexole—Insomnia—Donepezil—Alzheimer's disease	4.21e-05	0.000282	CcSEcCtD
Pramipexole—Infection—Memantine—Alzheimer's disease	4.2e-05	0.000282	CcSEcCtD
Pramipexole—Paraesthesia—Donepezil—Alzheimer's disease	4.18e-05	0.00028	CcSEcCtD
Pramipexole—Confusional state—Rivastigmine—Alzheimer's disease	4.17e-05	0.00028	CcSEcCtD
Pramipexole—Shock—Memantine—Alzheimer's disease	4.16e-05	0.000279	CcSEcCtD
Pramipexole—Dyspnoea—Donepezil—Alzheimer's disease	4.15e-05	0.000278	CcSEcCtD
Pramipexole—Nervous system disorder—Memantine—Alzheimer's disease	4.15e-05	0.000278	CcSEcCtD
Pramipexole—Somnolence—Donepezil—Alzheimer's disease	4.14e-05	0.000278	CcSEcCtD
Pramipexole—Thrombocytopenia—Memantine—Alzheimer's disease	4.14e-05	0.000278	CcSEcCtD
Pramipexole—Oedema—Rivastigmine—Alzheimer's disease	4.14e-05	0.000277	CcSEcCtD
Pramipexole—Tachycardia—Memantine—Alzheimer's disease	4.13e-05	0.000277	CcSEcCtD
Pramipexole—Diarrhoea—Galantamine—Alzheimer's disease	4.11e-05	0.000276	CcSEcCtD
Pramipexole—Infection—Rivastigmine—Alzheimer's disease	4.11e-05	0.000276	CcSEcCtD
Pramipexole—Skin disorder—Memantine—Alzheimer's disease	4.11e-05	0.000275	CcSEcCtD
Pramipexole—Dyspepsia—Donepezil—Alzheimer's disease	4.1e-05	0.000275	CcSEcCtD
Pramipexole—Hyperhidrosis—Memantine—Alzheimer's disease	4.09e-05	0.000274	CcSEcCtD
Pramipexole—Shock—Rivastigmine—Alzheimer's disease	4.07e-05	0.000273	CcSEcCtD
Pramipexole—Nervous system disorder—Rivastigmine—Alzheimer's disease	4.06e-05	0.000272	CcSEcCtD
Pramipexole—Thrombocytopenia—Rivastigmine—Alzheimer's disease	4.05e-05	0.000272	CcSEcCtD
Pramipexole—Decreased appetite—Donepezil—Alzheimer's disease	4.05e-05	0.000271	CcSEcCtD
Pramipexole—Tachycardia—Rivastigmine—Alzheimer's disease	4.04e-05	0.000271	CcSEcCtD
Pramipexole—Anorexia—Memantine—Alzheimer's disease	4.03e-05	0.00027	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Donepezil—Alzheimer's disease	4.02e-05	0.00027	CcSEcCtD
Pramipexole—Skin disorder—Rivastigmine—Alzheimer's disease	4.02e-05	0.000269	CcSEcCtD
Pramipexole—Fatigue—Donepezil—Alzheimer's disease	4.02e-05	0.000269	CcSEcCtD
Pramipexole—Hyperhidrosis—Rivastigmine—Alzheimer's disease	4e-05	0.000268	CcSEcCtD
Pramipexole—Pain—Donepezil—Alzheimer's disease	3.98e-05	0.000267	CcSEcCtD
Pramipexole—Constipation—Donepezil—Alzheimer's disease	3.98e-05	0.000267	CcSEcCtD
Pramipexole—Dizziness—Galantamine—Alzheimer's disease	3.97e-05	0.000266	CcSEcCtD
Pramipexole—Hypotension—Memantine—Alzheimer's disease	3.95e-05	0.000265	CcSEcCtD
Pramipexole—Anorexia—Rivastigmine—Alzheimer's disease	3.94e-05	0.000264	CcSEcCtD
Pramipexole—Hypotension—Rivastigmine—Alzheimer's disease	3.87e-05	0.000259	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Memantine—Alzheimer's disease	3.85e-05	0.000258	CcSEcCtD
Pramipexole—Feeling abnormal—Donepezil—Alzheimer's disease	3.84e-05	0.000257	CcSEcCtD
Pramipexole—Insomnia—Memantine—Alzheimer's disease	3.82e-05	0.000256	CcSEcCtD
Pramipexole—Vomiting—Galantamine—Alzheimer's disease	3.82e-05	0.000256	CcSEcCtD
Pramipexole—Gastrointestinal pain—Donepezil—Alzheimer's disease	3.81e-05	0.000255	CcSEcCtD
Pramipexole—Paraesthesia—Memantine—Alzheimer's disease	3.8e-05	0.000255	CcSEcCtD
Pramipexole—Rash—Galantamine—Alzheimer's disease	3.79e-05	0.000254	CcSEcCtD
Pramipexole—Dermatitis—Galantamine—Alzheimer's disease	3.79e-05	0.000254	CcSEcCtD
Pramipexole—Dyspnoea—Memantine—Alzheimer's disease	3.77e-05	0.000253	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	3.77e-05	0.000253	CcSEcCtD
Pramipexole—Headache—Galantamine—Alzheimer's disease	3.76e-05	0.000252	CcSEcCtD
Pramipexole—Somnolence—Memantine—Alzheimer's disease	3.76e-05	0.000252	CcSEcCtD
Pramipexole—Insomnia—Rivastigmine—Alzheimer's disease	3.74e-05	0.000251	CcSEcCtD
Pramipexole—Dyspepsia—Memantine—Alzheimer's disease	3.72e-05	0.00025	CcSEcCtD
Pramipexole—Paraesthesia—Rivastigmine—Alzheimer's disease	3.71e-05	0.000249	CcSEcCtD
Pramipexole—Urticaria—Donepezil—Alzheimer's disease	3.7e-05	0.000248	CcSEcCtD
Pramipexole—Dyspnoea—Rivastigmine—Alzheimer's disease	3.69e-05	0.000247	CcSEcCtD
Pramipexole—Abdominal pain—Donepezil—Alzheimer's disease	3.68e-05	0.000247	CcSEcCtD
Pramipexole—Body temperature increased—Donepezil—Alzheimer's disease	3.68e-05	0.000247	CcSEcCtD
Pramipexole—Somnolence—Rivastigmine—Alzheimer's disease	3.68e-05	0.000247	CcSEcCtD
Pramipexole—Decreased appetite—Memantine—Alzheimer's disease	3.68e-05	0.000246	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Memantine—Alzheimer's disease	3.65e-05	0.000245	CcSEcCtD
Pramipexole—Fatigue—Memantine—Alzheimer's disease	3.65e-05	0.000244	CcSEcCtD
Pramipexole—Dyspepsia—Rivastigmine—Alzheimer's disease	3.64e-05	0.000244	CcSEcCtD
Pramipexole—Constipation—Memantine—Alzheimer's disease	3.62e-05	0.000242	CcSEcCtD
Pramipexole—Pain—Memantine—Alzheimer's disease	3.62e-05	0.000242	CcSEcCtD
Pramipexole—Decreased appetite—Rivastigmine—Alzheimer's disease	3.6e-05	0.000241	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	3.57e-05	0.000239	CcSEcCtD
Pramipexole—Nausea—Galantamine—Alzheimer's disease	3.57e-05	0.000239	CcSEcCtD
Pramipexole—Fatigue—Rivastigmine—Alzheimer's disease	3.57e-05	0.000239	CcSEcCtD
Pramipexole—Constipation—Rivastigmine—Alzheimer's disease	3.54e-05	0.000237	CcSEcCtD
Pramipexole—Pain—Rivastigmine—Alzheimer's disease	3.54e-05	0.000237	CcSEcCtD
Pramipexole—Feeling abnormal—Memantine—Alzheimer's disease	3.48e-05	0.000234	CcSEcCtD
Pramipexole—Gastrointestinal pain—Memantine—Alzheimer's disease	3.46e-05	0.000232	CcSEcCtD
Pramipexole—Hypersensitivity—Donepezil—Alzheimer's disease	3.43e-05	0.00023	CcSEcCtD
Pramipexole—Feeling abnormal—Rivastigmine—Alzheimer's disease	3.41e-05	0.000229	CcSEcCtD
Pramipexole—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	3.38e-05	0.000227	CcSEcCtD
Pramipexole—Urticaria—Memantine—Alzheimer's disease	3.36e-05	0.000225	CcSEcCtD
Pramipexole—Abdominal pain—Memantine—Alzheimer's disease	3.34e-05	0.000224	CcSEcCtD
Pramipexole—Body temperature increased—Memantine—Alzheimer's disease	3.34e-05	0.000224	CcSEcCtD
Pramipexole—Asthenia—Donepezil—Alzheimer's disease	3.34e-05	0.000224	CcSEcCtD
Pramipexole—Pruritus—Donepezil—Alzheimer's disease	3.29e-05	0.000221	CcSEcCtD
Pramipexole—Urticaria—Rivastigmine—Alzheimer's disease	3.29e-05	0.00022	CcSEcCtD
Pramipexole—Body temperature increased—Rivastigmine—Alzheimer's disease	3.27e-05	0.000219	CcSEcCtD
Pramipexole—Abdominal pain—Rivastigmine—Alzheimer's disease	3.27e-05	0.000219	CcSEcCtD
Pramipexole—Diarrhoea—Donepezil—Alzheimer's disease	3.19e-05	0.000214	CcSEcCtD
Pramipexole—Hypersensitivity—Memantine—Alzheimer's disease	3.12e-05	0.000209	CcSEcCtD
Pramipexole—Dizziness—Donepezil—Alzheimer's disease	3.08e-05	0.000207	CcSEcCtD
Pramipexole—Hypersensitivity—Rivastigmine—Alzheimer's disease	3.05e-05	0.000204	CcSEcCtD
Pramipexole—Asthenia—Memantine—Alzheimer's disease	3.03e-05	0.000203	CcSEcCtD
Pramipexole—Pruritus—Memantine—Alzheimer's disease	2.99e-05	0.000201	CcSEcCtD
Pramipexole—Asthenia—Rivastigmine—Alzheimer's disease	2.97e-05	0.000199	CcSEcCtD
Pramipexole—Vomiting—Donepezil—Alzheimer's disease	2.96e-05	0.000199	CcSEcCtD
Pramipexole—Rash—Donepezil—Alzheimer's disease	2.94e-05	0.000197	CcSEcCtD
Pramipexole—Dermatitis—Donepezil—Alzheimer's disease	2.93e-05	0.000197	CcSEcCtD
Pramipexole—Pruritus—Rivastigmine—Alzheimer's disease	2.93e-05	0.000196	CcSEcCtD
Pramipexole—Headache—Donepezil—Alzheimer's disease	2.92e-05	0.000196	CcSEcCtD
Pramipexole—Diarrhoea—Memantine—Alzheimer's disease	2.89e-05	0.000194	CcSEcCtD
Pramipexole—Diarrhoea—Rivastigmine—Alzheimer's disease	2.83e-05	0.00019	CcSEcCtD
Pramipexole—Dizziness—Memantine—Alzheimer's disease	2.8e-05	0.000188	CcSEcCtD
Pramipexole—Nausea—Donepezil—Alzheimer's disease	2.77e-05	0.000185	CcSEcCtD
Pramipexole—Dizziness—Rivastigmine—Alzheimer's disease	2.74e-05	0.000183	CcSEcCtD
Pramipexole—Vomiting—Memantine—Alzheimer's disease	2.69e-05	0.00018	CcSEcCtD
Pramipexole—Rash—Memantine—Alzheimer's disease	2.67e-05	0.000179	CcSEcCtD
Pramipexole—Dermatitis—Memantine—Alzheimer's disease	2.66e-05	0.000179	CcSEcCtD
Pramipexole—Headache—Memantine—Alzheimer's disease	2.65e-05	0.000178	CcSEcCtD
Pramipexole—Vomiting—Rivastigmine—Alzheimer's disease	2.63e-05	0.000176	CcSEcCtD
Pramipexole—Rash—Rivastigmine—Alzheimer's disease	2.61e-05	0.000175	CcSEcCtD
Pramipexole—Dermatitis—Rivastigmine—Alzheimer's disease	2.61e-05	0.000175	CcSEcCtD
Pramipexole—Headache—Rivastigmine—Alzheimer's disease	2.59e-05	0.000174	CcSEcCtD
Pramipexole—Nausea—Memantine—Alzheimer's disease	2.51e-05	0.000168	CcSEcCtD
Pramipexole—Nausea—Rivastigmine—Alzheimer's disease	2.46e-05	0.000165	CcSEcCtD
Pramipexole—HTR2A—Signaling Pathways—NGF—Alzheimer's disease	2.77e-06	5.57e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—CALM1—Alzheimer's disease	2.75e-06	5.54e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—NOS3—Alzheimer's disease	2.74e-06	5.52e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—APOE—Alzheimer's disease	2.74e-06	5.52e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—LEP—Alzheimer's disease	2.74e-06	5.52e-05	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—PPARG—Alzheimer's disease	2.74e-06	5.51e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—CCR5—Alzheimer's disease	2.73e-06	5.51e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—CCL2—Alzheimer's disease	2.73e-06	5.5e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—IGF1—Alzheimer's disease	2.72e-06	5.48e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—CAV1—Alzheimer's disease	2.72e-06	5.47e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—NOTCH1—Alzheimer's disease	2.71e-06	5.46e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—ESR1—Alzheimer's disease	2.71e-06	5.45e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—ESR1—Alzheimer's disease	2.69e-06	5.42e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—CCR5—Alzheimer's disease	2.69e-06	5.42e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—IGF1—Alzheimer's disease	2.69e-06	5.41e-05	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—INS—Alzheimer's disease	2.68e-06	5.41e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Hemostasis—TP53—Alzheimer's disease	2.68e-06	5.4e-05	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—VEGFA—Alzheimer's disease	2.68e-06	5.39e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—HTR2A—Alzheimer's disease	2.68e-06	5.39e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—CALM1—Alzheimer's disease	2.67e-06	5.38e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—F2—Alzheimer's disease	2.67e-06	5.38e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—APOE—Alzheimer's disease	2.66e-06	5.36e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—F2—Alzheimer's disease	2.66e-06	5.35e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—LPL—Alzheimer's disease	2.66e-06	5.35e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—CAV1—Alzheimer's disease	2.64e-06	5.31e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—MEF2C—Alzheimer's disease	2.63e-06	5.3e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—NOS3—Alzheimer's disease	2.62e-06	5.27e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—ESR1—Alzheimer's disease	2.62e-06	5.27e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—NOTCH1—Alzheimer's disease	2.62e-06	5.27e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—NOTCH1—Alzheimer's disease	2.6e-06	5.24e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—F2—Alzheimer's disease	2.59e-06	5.21e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—PRKCG—Alzheimer's disease	2.58e-06	5.2e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—GSK3B—Alzheimer's disease	2.54e-06	5.12e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—NOTCH1—Alzheimer's disease	2.53e-06	5.1e-05	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—NOS3—Alzheimer's disease	2.53e-06	5.09e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—CREB1—Alzheimer's disease	2.52e-06	5.08e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—NGF—Alzheimer's disease	2.52e-06	5.07e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—INS—Alzheimer's disease	2.51e-06	5.05e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—CALM1—Alzheimer's disease	2.5e-06	5.03e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—LEP—Alzheimer's disease	2.49e-06	5.01e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—APOE—Alzheimer's disease	2.49e-06	5.01e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—NOS3—Alzheimer's disease	2.47e-06	4.97e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—CCL2—Alzheimer's disease	2.47e-06	4.97e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—CAV1—Alzheimer's disease	2.47e-06	4.96e-05	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—TGFB1—Alzheimer's disease	2.46e-06	4.95e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—NOS3—Alzheimer's disease	2.46e-06	4.95e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—CALM1—Alzheimer's disease	2.46e-06	4.95e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—GSK3B—Alzheimer's disease	2.45e-06	4.94e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—LEP—Alzheimer's disease	2.45e-06	4.93e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—APOE—Alzheimer's disease	2.45e-06	4.93e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CCR5—Alzheimer's disease	2.45e-06	4.93e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—GSK3B—Alzheimer's disease	2.44e-06	4.92e-05	CbGpPWpGaD
Pramipexole—HTR1D—GPCR downstream signaling—AKT1—Alzheimer's disease	2.44e-06	4.91e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—NOS3—Alzheimer's disease	2.44e-06	4.91e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—CREB1—Alzheimer's disease	2.43e-06	4.9e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—IGF1—Alzheimer's disease	2.43e-06	4.88e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—CAV1—Alzheimer's disease	2.43e-06	4.88e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—CREB1—Alzheimer's disease	2.42e-06	4.88e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—INS—Alzheimer's disease	2.42e-06	4.88e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—CASP3—Alzheimer's disease	2.42e-06	4.87e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—INS—Alzheimer's disease	2.41e-06	4.85e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling by GPCR—IL6—Alzheimer's disease	2.4e-06	4.83e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—HTR2A—Alzheimer's disease	2.4e-06	4.82e-05	CbGpPWpGaD
Pramipexole—HTR1B—GPCR downstream signaling—AKT1—Alzheimer's disease	2.39e-06	4.81e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—CCL2—Alzheimer's disease	2.38e-06	4.8e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—ESR1—Alzheimer's disease	2.38e-06	4.78e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—GSK3B—Alzheimer's disease	2.37e-06	4.78e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—CCL2—Alzheimer's disease	2.37e-06	4.77e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—CASP3—Alzheimer's disease	2.37e-06	4.76e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—CREB1—Alzheimer's disease	2.36e-06	4.74e-05	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—NOS3—Alzheimer's disease	2.35e-06	4.74e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling by GPCR—IL6—Alzheimer's disease	2.35e-06	4.73e-05	CbGpPWpGaD
Pramipexole—DRD4—GPCR downstream signaling—AKT1—Alzheimer's disease	2.35e-06	4.73e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—F2—Alzheimer's disease	2.35e-06	4.73e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—INS—Alzheimer's disease	2.34e-06	4.72e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—IGF1—Alzheimer's disease	2.34e-06	4.72e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—ESR1—Alzheimer's disease	2.34e-06	4.71e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—IGF1—Alzheimer's disease	2.33e-06	4.69e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—CASP3—Alzheimer's disease	2.33e-06	4.69e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—PPARG—Alzheimer's disease	2.32e-06	4.67e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling by GPCR—IL6—Alzheimer's disease	2.31e-06	4.66e-05	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—PTGS2—Alzheimer's disease	2.31e-06	4.65e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—F2—Alzheimer's disease	2.31e-06	4.65e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—CCL2—Alzheimer's disease	2.3e-06	4.64e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—NOTCH1—Alzheimer's disease	2.3e-06	4.62e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—INS—Alzheimer's disease	2.28e-06	4.58e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—IGF1—Alzheimer's disease	2.27e-06	4.56e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Hemostasis—AKT1—Alzheimer's disease	2.26e-06	4.56e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—NOTCH1—Alzheimer's disease	2.26e-06	4.55e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—PTGS2—Alzheimer's disease	2.25e-06	4.53e-05	CbGpPWpGaD
Pramipexole—HTR2B—GPCR downstream signaling—AKT1—Alzheimer's disease	2.24e-06	4.52e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CALM1—Alzheimer's disease	2.24e-06	4.5e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—LEP—Alzheimer's disease	2.23e-06	4.49e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—APOE—Alzheimer's disease	2.23e-06	4.49e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—CASP3—Alzheimer's disease	2.22e-06	4.48e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—MAPK8—Alzheimer's disease	2.22e-06	4.47e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling by GPCR—AKT1—Alzheimer's disease	2.21e-06	4.46e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—IL6—Alzheimer's disease	2.21e-06	4.45e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CAV1—Alzheimer's disease	2.21e-06	4.44e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—NOS3—Alzheimer's disease	2.2e-06	4.43e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—MAPK8—Alzheimer's disease	2.17e-06	4.38e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling by GPCR—AKT1—Alzheimer's disease	2.17e-06	4.37e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—GSK3B—Alzheimer's disease	2.15e-06	4.34e-05	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—PTGS2—Alzheimer's disease	2.15e-06	4.34e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—MAPK8—Alzheimer's disease	2.14e-06	4.31e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—CREB1—Alzheimer's disease	2.14e-06	4.3e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling by GPCR—AKT1—Alzheimer's disease	2.13e-06	4.3e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—ESR1—Alzheimer's disease	2.13e-06	4.28e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—INS—Alzheimer's disease	2.13e-06	4.28e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—NOS3—Alzheimer's disease	2.12e-06	4.28e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—GSK3B—Alzheimer's disease	2.12e-06	4.27e-05	CbGpPWpGaD
Pramipexole—DRD1—GPCR downstream signaling—AKT1—Alzheimer's disease	2.12e-06	4.26e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—NOS3—Alzheimer's disease	2.11e-06	4.25e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—CREB1—Alzheimer's disease	2.1e-06	4.24e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—F2—Alzheimer's disease	2.1e-06	4.23e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—CASP3—Alzheimer's disease	2.1e-06	4.22e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—INS—Alzheimer's disease	2.09e-06	4.21e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—CCL2—Alzheimer's disease	2.09e-06	4.21e-05	CbGpPWpGaD
Pramipexole—DRD3—GPCR downstream signaling—AKT1—Alzheimer's disease	2.09e-06	4.2e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—IL6—Alzheimer's disease	2.08e-06	4.19e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—CASP3—Alzheimer's disease	2.07e-06	4.16e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—CCL2—Alzheimer's disease	2.06e-06	4.14e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—IGF1—Alzheimer's disease	2.06e-06	4.14e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—NOTCH1—Alzheimer's disease	2.06e-06	4.14e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—IL6—Alzheimer's disease	2.05e-06	4.14e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—NOS3—Alzheimer's disease	2.05e-06	4.14e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—VEGFA—Alzheimer's disease	2.05e-06	4.13e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—MAPK8—Alzheimer's disease	2.04e-06	4.11e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—AKT1—Alzheimer's disease	2.04e-06	4.1e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—IGF1—Alzheimer's disease	2.02e-06	4.07e-05	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—TP53—Alzheimer's disease	2.02e-06	4.07e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—VEGFA—Alzheimer's disease	2.01e-06	4.04e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—NOS3—Alzheimer's disease	2e-06	4.02e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—VEGFA—Alzheimer's disease	1.98e-06	3.98e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—GSK3B—Alzheimer's disease	1.93e-06	3.88e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—MAPK8—Alzheimer's disease	1.93e-06	3.88e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—AKT1—Alzheimer's disease	1.92e-06	3.87e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CREB1—Alzheimer's disease	1.91e-06	3.85e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—INS—Alzheimer's disease	1.9e-06	3.83e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—MAPK8—Alzheimer's disease	1.9e-06	3.83e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—AKT1—Alzheimer's disease	1.9e-06	3.82e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—VEGFA—Alzheimer's disease	1.89e-06	3.8e-05	CbGpPWpGaD
Pramipexole—ADRA2B—GPCR downstream signaling—AKT1—Alzheimer's disease	1.88e-06	3.8e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—TGFB1—Alzheimer's disease	1.88e-06	3.79e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CCL2—Alzheimer's disease	1.87e-06	3.77e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—CASP3—Alzheimer's disease	1.87e-06	3.76e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—NOS3—Alzheimer's disease	1.86e-06	3.75e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—IL6—Alzheimer's disease	1.85e-06	3.74e-05	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—IL6—Alzheimer's disease	1.85e-06	3.73e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—TGFB1—Alzheimer's disease	1.84e-06	3.71e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—IGF1—Alzheimer's disease	1.84e-06	3.71e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—NOS3—Alzheimer's disease	1.83e-06	3.69e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—PTGS2—Alzheimer's disease	1.83e-06	3.68e-05	CbGpPWpGaD
Pramipexole—HTR1A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.82e-06	3.66e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—TGFB1—Alzheimer's disease	1.81e-06	3.65e-05	CbGpPWpGaD
Pramipexole—HTR2C—GPCR downstream signaling—AKT1—Alzheimer's disease	1.81e-06	3.64e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—CASP3—Alzheimer's disease	1.8e-06	3.63e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—CASP3—Alzheimer's disease	1.79e-06	3.61e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—IL6—Alzheimer's disease	1.79e-06	3.61e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—IL6—Alzheimer's disease	1.78e-06	3.59e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—VEGFA—Alzheimer's disease	1.78e-06	3.58e-05	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR downstream signaling—AKT1—Alzheimer's disease	1.76e-06	3.55e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—VEGFA—Alzheimer's disease	1.75e-06	3.53e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—CASP3—Alzheimer's disease	1.74e-06	3.51e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—IL6—Alzheimer's disease	1.73e-06	3.49e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—TGFB1—Alzheimer's disease	1.73e-06	3.49e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—MAPK8—Alzheimer's disease	1.72e-06	3.46e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—AKT1—Alzheimer's disease	1.71e-06	3.45e-05	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—AKT1—Alzheimer's disease	1.71e-06	3.44e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—NOS3—Alzheimer's disease	1.67e-06	3.36e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—MAPK8—Alzheimer's disease	1.66e-06	3.34e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—AKT1—Alzheimer's disease	1.65e-06	3.33e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—MAPK8—Alzheimer's disease	1.65e-06	3.32e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—AKT1—Alzheimer's disease	1.64e-06	3.31e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—TGFB1—Alzheimer's disease	1.63e-06	3.29e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—TGFB1—Alzheimer's disease	1.61e-06	3.24e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—MAPK8—Alzheimer's disease	1.6e-06	3.23e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—AKT1—Alzheimer's disease	1.6e-06	3.22e-05	CbGpPWpGaD
Pramipexole—DRD2—GPCR downstream signaling—AKT1—Alzheimer's disease	1.6e-06	3.22e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—VEGFA—Alzheimer's disease	1.58e-06	3.19e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—CASP3—Alzheimer's disease	1.58e-06	3.19e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—IL6—Alzheimer's disease	1.57e-06	3.17e-05	CbGpPWpGaD
Pramipexole—HTR2A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.57e-06	3.16e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—CASP3—Alzheimer's disease	1.56e-06	3.14e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—TP53—Alzheimer's disease	1.55e-06	3.12e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—IL6—Alzheimer's disease	1.55e-06	3.12e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—VEGFA—Alzheimer's disease	1.53e-06	3.08e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—VEGFA—Alzheimer's disease	1.52e-06	3.06e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—TP53—Alzheimer's disease	1.52e-06	3.06e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—TP53—Alzheimer's disease	1.49e-06	3.01e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—VEGFA—Alzheimer's disease	1.48e-06	2.98e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—MAPK8—Alzheimer's disease	1.45e-06	2.93e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—TGFB1—Alzheimer's disease	1.45e-06	2.93e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—AKT1—Alzheimer's disease	1.45e-06	2.92e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—MAPK8—Alzheimer's disease	1.43e-06	2.88e-05	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.43e-06	2.88e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—AKT1—Alzheimer's disease	1.43e-06	2.87e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—TP53—Alzheimer's disease	1.43e-06	2.87e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—IL6—Alzheimer's disease	1.42e-06	2.86e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CASP3—Alzheimer's disease	1.42e-06	2.85e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—IL6—Alzheimer's disease	1.41e-06	2.83e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—TGFB1—Alzheimer's disease	1.4e-06	2.83e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—TGFB1—Alzheimer's disease	1.4e-06	2.81e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—IL6—Alzheimer's disease	1.39e-06	2.8e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—IL6—Alzheimer's disease	1.37e-06	2.75e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—TGFB1—Alzheimer's disease	1.36e-06	2.74e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—TP53—Alzheimer's disease	1.34e-06	2.71e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—VEGFA—Alzheimer's disease	1.34e-06	2.7e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—TP53—Alzheimer's disease	1.33e-06	2.67e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—VEGFA—Alzheimer's disease	1.32e-06	2.66e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—AKT1—Alzheimer's disease	1.31e-06	2.63e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—IL6—Alzheimer's disease	1.3e-06	2.63e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—MAPK8—Alzheimer's disease	1.3e-06	2.62e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—AKT1—Alzheimer's disease	1.3e-06	2.61e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—AKT1—Alzheimer's disease	1.28e-06	2.58e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—AKT1—Alzheimer's disease	1.26e-06	2.54e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—TGFB1—Alzheimer's disease	1.23e-06	2.48e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—IL6—Alzheimer's disease	1.23e-06	2.48e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—IL6—Alzheimer's disease	1.21e-06	2.44e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—TGFB1—Alzheimer's disease	1.21e-06	2.44e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—AKT1—Alzheimer's disease	1.2e-06	2.42e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—VEGFA—Alzheimer's disease	1.2e-06	2.42e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—TP53—Alzheimer's disease	1.2e-06	2.41e-05	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—AKT1—Alzheimer's disease	1.16e-06	2.34e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—TP53—Alzheimer's disease	1.16e-06	2.33e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—TP53—Alzheimer's disease	1.15e-06	2.32e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—AKT1—Alzheimer's disease	1.13e-06	2.29e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—AKT1—Alzheimer's disease	1.13e-06	2.27e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—AKT1—Alzheimer's disease	1.12e-06	2.26e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—TP53—Alzheimer's disease	1.12e-06	2.25e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—TGFB1—Alzheimer's disease	1.1e-06	2.22e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—IL6—Alzheimer's disease	1.1e-06	2.21e-05	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—AKT1—Alzheimer's disease	1.08e-06	2.18e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—IL6—Alzheimer's disease	1.06e-06	2.13e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—IL6—Alzheimer's disease	1.05e-06	2.12e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—IL6—Alzheimer's disease	1.02e-06	2.06e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—TP53—Alzheimer's disease	1.01e-06	2.04e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—AKT1—Alzheimer's disease	1.01e-06	2.04e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—TP53—Alzheimer's disease	9.98e-07	2.01e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—AKT1—Alzheimer's disease	9.76e-07	1.97e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—AKT1—Alzheimer's disease	9.71e-07	1.96e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—AKT1—Alzheimer's disease	9.44e-07	1.9e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—IL6—Alzheimer's disease	9.29e-07	1.87e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—AKT1—Alzheimer's disease	9.17e-07	1.85e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—IL6—Alzheimer's disease	9.14e-07	1.84e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—TP53—Alzheimer's disease	9.08e-07	1.83e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—AKT1—Alzheimer's disease	8.57e-07	1.73e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—AKT1—Alzheimer's disease	8.43e-07	1.7e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—IL6—Alzheimer's disease	8.31e-07	1.67e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—AKT1—Alzheimer's disease	7.67e-07	1.54e-05	CbGpPWpGaD
